Impact of the Human Genome Project at the interface between patent and FDA laws.
D026683:Advisory Committees; D004274:DNA, Recombinant; D003657:Decision Making; D035082:Federal Government; D036281:Genetic Research; D015316:Genetic Therapy; D005823:Genetics; D006076:Government; D033161:Government Regulation; D016045:Human Genome Project; D006801:Humans; D007221:Industry; D007603:Jurisprudence; D030781:Organisms, Genetically Modified; D010330:Patents as Topic; D011640:Public Policy; D012926:Social Control, Formal; D014481:United States; D014486:United States Food and Drug Administration
Biomedical and Behavioral Research; Diamond v. Chakrabarty; Genetics and Reproduction; Human Genome Project; Legal Approach; Patent and Trademark Office; Recombinant DNA Advisory Committee